Lemborexant 10 MG Clinical Trials
2 recruitingDrug
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia.
Insomnia
Woolcock Institute of Medical Research20 enrolled1 locationNCT06823752
Recruiting
Phase 2
Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects
Opioid UseInsomniaOpioid-use Disorder+1 more
Virginia Commonwealth University100 enrolled1 locationNCT06981195